The Zacks Analyst Blog Highlights Abercrombie & Fitch, InterDigital, Shake Shack, Amphastar and PGT Innovations
For Immediate Release
Chicago, IL – July 20, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Abercrombie & Fitch Co. ANF, InterDigital Inc. IDCC, Shake Shack Inc. SHAK, Amphastar Pharmaceuticals Inc. AMPH and PGT Innovations Inc. PGTI.
Here are highlights from Wednesday’s Analyst Blog:
5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio
Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy. These stocks combine the attractive attributes of both small and large-cap stocks. Top-ranked mid-cap stocks have a high potential of enhancing their profitability, productivity and market share. These may also become large caps in due course of time.
If the economy faces any unforeseen internal or external disturbance, mid-cap stocks will be less susceptible to losses than their large-cap counterparts owing to their less international exposure. On the other hand, if the economy remains stable, these stocks will gain more than small caps due to established management teams, a broad distribution network, brand recognition and ready access to the capital markets.
In the first and second quarters of 2023, like the three major stock indexes, the mid-cap-centric S&P 400 Index ended in positive territory, advancing 3.4% and 4.4%, respectively. Year to date, the S&P 400 has rallied 10.7%.
At this stage, it will be prudent to invest in mid-cap stocks to tap the broad-based ongoing rally of 2023.
Our Top Picks
We have narrowed our search to five mid-cap (market capital > $1 billion < $10 billion) stocks with more than 50% returns year to date. These stocks have more upside left for the rest of 2023. These stocks have seen positive earnings estimate revisions in the last 60 days. Each of our picks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Abercrombie & Fitch Co. has gained from the continued momentum in the Abercrombie brand and improvement in the Hollister brand. Lower freight costs and robust AUR growth aided ANF’s margins. Consequently, ANF expects fiscal 2023 sales growth of 1-3% from the year-ago period’s reported figure of $3.7 billion. ANF’s store optimization and the Always Forward plan bode well.
Abercrombie & Fitch has an expected revenue and earnings growth rate of 3.4% and more than 100%, respectively, for the current year (ending January 2024). The Zacks Consensus Estimate for current-year earnings has improved 45.6% over the last 60 days. The stock price of ANF has surged 62.2% year to date.
InterDigital Inc. is focused on strategic acquisitions in order to drive its product portfolio and boost organic growth. IDCC’s extensive portfolio of wireless technology patents provides a significant competitive advantage. IDCC is poised to gain from future growth opportunities fueled by the 5G rollout, while a strong emphasis on research & development helps it to stay at the forefront of wireless technology innovation.
InterDigital has an expected revenue and earnings growth rate of 17.4% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.1% over the last 60 days. The stock price of IDCC has jumped 95.3% year to date.
Shake Shack Inc. has been benefiting from various digital initiatives, strong same-shack sales and unit expansion efforts. SHAK’s digital retention continues to be strong. It has also been making more investments in digitization in an effort to sustain its digital guest enhancement strategies in the near term.
Shake Shack has an expected revenue and earnings growth rate of 21.5% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 60 days. The stock price of SHAK has climbed 92.4% year to date.
Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company. AMPH focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. AMPH’s products include Enoxaparin Sodium Injection, Amphadase, Cortrosyn for Injection, and prefilled disposable emergency syringes for crash cart use.
Amphastar Pharmaceuticals has an expected revenue and earnings growth rate of 17.4% and 30%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.8% over the last 60 days. The stock price of AMPH has soared 118% year to date.
PGT Innovations Inc. pioneered the U.S. impact-resistant window and door industry and today is the nation's leading manufacturer and supplier of residential impact-resistant windows and doors. PGTI is also one of the largest window and door manufacturers in the United States.
PGTI’s total line of custom windows and doors is now available throughout the eastern United States, the Gulf Coast and in a growing international market, which includes the Caribbean, South America, and Australia.
PGT Innovations has an expected revenue and earnings growth rate of 0.5% and 8.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.5% over the last seven days. The stock price of PGTI has advanced 57.8% year to date.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Abercrombie & Fitch Company (ANF) : Free Stock Analysis Report
Amphastar Pharmaceuticals, Inc. (AMPH) : Free Stock Analysis Report
InterDigital, Inc. (IDCC) : Free Stock Analysis Report
PGT, Inc. (PGTI) : Free Stock Analysis Report
Shake Shack, Inc. (SHAK) : Free Stock Analysis Report
